CAS 180272-28-0
:N-oxyde de solifénacine
- (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3R)-1-Oxido-1-azabicyclo[2.2.2]oct-3-yl Ester
- (1R,3R,4R)-3-((1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)oxy)quinuclidine 1-oxide
(R)-3-(((S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)oxy)quinuclidine 1-oxide
CAS :Formule :C23H26N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :378.4641Solifenacin EP Impurity I (Solifenacin N-Oxide)
CAS :Formule :C23H26N2O3Couleur et forme :Off-White SolidMasse moléculaire :378.47Solifenacin EP Impurity I-d5 (Solifenacin-N-Oxide-d5)
CAS :Formule :C23H21D5N2O3Masse moléculaire :383.50Solifenacin N-Oxide
CAS :Produit contrôléStability Very Hygroscopic
Applications A metabolite of Solifenacin (S676700) .
References Hammerlein, A., et al.: Clin. Pharmacokinet., 35, 49 (1998), Schwartz, J., et al.: Clin. Pharmacol. Ther., 55, 509 (1994),Wein, A., et al.: Expert Opin. Investig. Drugs, 10, 65 (2001),Formule :C23H26N2O3Couleur et forme :NeatMasse moléculaire :378.46Solifenacin N-oxide
CAS :Solifenacin N-oxide is an anti-cholinergic agent that has been shown to be effective in the treatment of overactive bladder. Solifenacin N-oxide is a prodrug that is hydrolyzed in vivo to solifenacin, its active form. The compound reversibly binds to muscarinic receptors and inhibits the release of acetylcholine. Solifenacin N-oxide has been shown to have low levels of impurities and is highly soluble in water. It was also found to be stable when stored at room temperature for two months. This drug has a high flow rate and moderate retention time, which makes it suitable for reversed-phase liquid chromatography (RPLC). RPLC is a chromatographic technique that separates compounds by size, hydrophobicity, or charge.
Formule :C23H26N2O3Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :378.46 g/mol





